| A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system A Dokoumetzidis, P Macheras International journal of pharmaceutics 321 (1-2), 1-11, 2006 | 929 | 2006 |
| On the use of the Weibull function for the discernment of drug release mechanisms V Papadopoulou, K Kosmidis, M Vlachou, P Macheras International journal of pharmaceutics 309 (1-2), 44-50, 2006 | 821 | 2006 |
| Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches P Macheras, A Iliadis Springer, 2016 | 259 | 2016 |
| Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio E Rinaki, G Valsami, P Macheras Pharmaceutical research 20, 1917-1925, 2003 | 255 | 2003 |
| A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function K Kosmidis, P Argyrakis, P Macheras Pharmaceutical research 20, 988-995, 2003 | 246 | 2003 |
| In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15 A Boobis, U Gundert-Remy, P Kremers, P Macheras, O Pelkonen European Journal of Pharmaceutical Sciences 17 (4-5), 183-193, 2002 | 211 | 2002 |
| Fractal kinetics in drug release from finite fractal matrices K Kosmidis, P Argyrakis, P Macheras The Journal of chemical physics 119 (12), 6373-6377, 2003 | 183 | 2003 |
| The biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS): beyond guidelines A Charalabidis, M Sfouni, C Bergström, P Macheras International journal of pharmaceutics 566, 264-281, 2019 | 181 | 2019 |
| Fractional kinetics in drug absorption and disposition processes A Dokoumetzidis, P Macheras Journal of pharmacokinetics and pharmacodynamics 36, 165-178, 2009 | 164 | 2009 |
| Analysis of dissolution data using modified versions of Noyes–Whitney equation and the Weibull function A Dokoumetzidis, V Papadopoulou, P Macheras Pharmaceutical research 23, 256-261, 2006 | 162 | 2006 |
| A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ... The AAPS journal 15, 1072-1081, 2013 | 141 | 2013 |
| Fractional kinetics in multi-compartmental systems A Dokoumetzidis, R Magin, P Macheras Journal of pharmacokinetics and pharmacodynamics 37, 507-524, 2010 | 136 | 2010 |
| On the heterogeneity of drug dissolution and release P Macheras, A Dokoumetzidis Pharmaceutical research 17, 108-112, 2000 | 128 | 2000 |
| The power law can describe the ‘entire’drug release curve from HPMC-based matrix tablets: a hypothesis E Rinaki, G Valsami, P Macheras International journal of pharmaceutics 255 (1-2), 199-207, 2003 | 117 | 2003 |
| A commentary on fractionalization of multi-compartmental models A Dokoumetzidis, R Magin, P Macheras Journal of pharmacokinetics and pharmacodynamics 37, 203-207, 2010 | 113 | 2010 |
| Identification of biowaivers among class II drugs: theoretical justification and practical examples E Rinaki, A Dokoumetzidis, G Valsami, P Macheras Pharmaceutical Research 21, 1567-1572, 2004 | 109 | 2004 |
| Fractional calculus in pharmacokinetics P Sopasakis, H Sarimveis, P Macheras, A Dokoumetzidis Journal of pharmacokinetics and pharmacodynamics 45, 107-125, 2018 | 107 | 2018 |
| Analysis of Case II drug transport with radial and axial release from cylinders K Kosmidis, E Rinaki, P Argyrakis, P Macheras International journal of pharmaceutics 254 (2), 183-188, 2003 | 100 | 2003 |
| Biopharmaceutics of orally administered drugs P Macheras CRC Press, 1995 | 99 | 1995 |
| The mean dissolution time depends on the dose/solubility ratio E Rinaki, A Dokoumetzidis, P Macheras Pharmaceutical research 20, 406-408, 2003 | 97 | 2003 |
